| Acquirer | Target | Price |
|---|---|---|
| ProStrakan Group plc | Rights to Moventig | $70 million |
| Ipsen | Exclusive license to cabozantinib | $200 million |
| UPMC Enterprises | N/A | |
| Ascension Wisconsin | Wheaton Franciscan Healthcare | Merger |
| Civitas Solutions, Inc. | Tender Loving Care of Duluth, Inc. | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
